Results 231 to 240 of about 337,805 (303)

Screening and epitope characterization of Nidogen‐2‐specific nanobodies

FEBS Open Bio, Volume 16, Issue 8, Page 1459-1476, August 2026.
Camel immunization and phage display were employed to generate high‐affinity VHH nanobodies against Nidogen‐2. After library construction, biopanning, ELISA screening, sequencing, and recombinant expression, selected nanobodies were purified and characterized, leading to the preliminary exploration of a nanobody‐based sandwich ELISA for specific ...
Jianchuan Wen, Qianqian Cui, Zhongyun Lan, Yingjun Wang, Shuaiying Zhao, Wenxuan Feng, Yunfeng Liu, Qiting Huang, Dongna Zhang, Jianfeng Xu   +9 more
wiley   +1 more source

Retraction: PTIP inhibits cell invasion in esophageal squamous cell carcinoma <i>via</i> modulation of EphA2 expression. [PDF]

Front Oncol
Frontiers Editorial Office.
europepmc   +1 more source

Nonviral Gold Nanoparticle‐Mediated Delivery of CRISPR‐Cas9 Ribonucleoprotein and Long DNA Transgenes Into Primary Blood Cells

Advanced NanoBiomed Research, Volume 6, Issue 8, August 2026.
CRISPR/Cas9 has revolutionized the field of gene therapy, but delivery remains an outstanding issue. We propose a nonviral gold‐nanoparticle platform for co‐delivery of CRISPR/Cas9 ribonucleoprotein and long 2.1 kilobase dsDNA transgene constructs. This CRISPR‐AuNP is inexpensive to produce and mediate gene editing and DNA delivery in T cells and CD34+
Rachel A. Cunningham, Karthikeya S. V. Gottimukkala, Daniel D. Lane, Katrina Poljakov, Patricia Lipson, Mark R. Enstrom, Alessandro Rizzi, Aude G. Chapuis, Jennifer E. Adair   +8 more
wiley   +1 more source

Predicting Post-Radiotherapy Lymphocyte Recovery for Individualized Risk Stratification in Locally Advanced Esophageal Squamous Cell Carcinoma. [PDF]

Curr Oncol
Ji H, Su Y, Liu M, Wang Y, An Q, Jia Y, Zhang Z, Yan J, Bai J, Zhang P, Zhou Z.   +10 more
europepmc   +1 more source

Low‐Dose Antiangiogenic Therapy With Different Chemotherapy Backbones Among Patients With Heavily Pretreated Metastatic Breast Cancer

Cancer Innovation, Volume 5, Issue 4, August 2026.
Antiangiogenic‐based regimens demonstrated superior efficacy compared to chemotherapy alone in heavily pretreated MBC patients, with manageable AEs. ABSTRACT Background The prognosis for metastatic breast cancer (MBC) remains poor, and treatment options are limited for patients with heavily pretreated disease. Although antiangiogenic agents may provide
Yuanyi Wang, Yalong Qi, Cheng Zeng, Ruixia Song, Yuhan Wei, Haili Qian, Fei Ma   +6 more
wiley   +1 more source

An Engineered Nano-Bridging Strategy Remodels the Immune Microenvironment of Esophageal Squamous Cell Carcinoma via STING Pathway Activation. [PDF]

MedComm (2020)
Huang C, Tang X, Zhao Y, Xu D, Sun C, Wang C, Xie F, Xu F, Luo C, Zhang L, Wang Q.   +10 more
europepmc   +1 more source

Multivariable Radiomics Model for Predicting Programmed Death‐Ligand 1 Expression After Neoadjuvant Chemoradiotherapy in Esophageal Squamous Cell Carcinoma

Cancer Medicine, Volume 15, Issue 8, August 2026.
ABSTRACT Background We aimed to develop models for predicting programmed death‐ligand 1 (PD‐L1) expression following neoadjuvant chemoradiotherapy (nCRT) in esophageal squamous cell carcinoma (ESCC) using a multifaceted approach that integrates traditional radiomics, deep learning, and machine learning.
Hyun Do Jung, Tae Hoon Lee, Byoung Hyuck Kim, Hye Seung Lee, Jaeman Son, Hwiyoung Kim, Hak Jae Kim   +6 more
wiley   +1 more source

Prior Cancer and Survival in Patients With Esophageal Squamous Cell Carcinoma.

JAMA Netw Open
Yu S, Hong JT, Jung HK, Lee HA, Jeong ES, Lee H, Don Choi K, Jung HY, Park JC, Kwon JG, Choi YJ, Hong SJ, Sung J, Chung WC, Kim KB, Kim SY, Song KH, Park KS, Jeon SW, Kim BW, Ryu HS, Lee OJ, Baik GH, Kim YS.   +23 more
europepmc   +1 more source

Esophageal squamous cell carcinoma in a patient with spinal cord injury complicated by achalasia: a case report. [PDF]

Front Oncol
Zhang Y, Li X.
europepmc   +1 more source

Overcoming Radiation Resistance: Ferroptosis Induction to Sensitize Solid Tumors to Radiation Therapy

Cancer Medicine, Volume 15, Issue 8, August 2026.
ABSTRACT Radiation therapy (RT) is a mainstay of treatment for a myriad of cancers, often utilized for tumors that are unable to be resected, as well as an adjunct to surgery and chemotherapy. Unfortunately, many cancers are resistant to RT‐induced damage and subsequent cell death.
Joseph Carmicheal, Caden M. Fritson, Alexandra Seas, Heidi Vieira, Surinder K. Batra   +4 more
wiley   +1 more source